Every week on http://www.***.com/
Chaque semaine sur http://www.***.com/

Press review  (December 24, 2011) Revue de presse (24 dcembre 2011)

Bristol-Myers: Experimental liver cancer drug failed in late-stage
study, other tests continue
A key experimental liver cancer drug (brivanib) that Bristol-Myers
Squibb Co. has been testing did not meet the main goal of a late-stage
study, the company said late Thursday.
Washington Post
http://www.***.com/

{*filter*} Cancer Patients Face More Imaging Tests Today
Study finds multiple visits common in pre-op period, urges better
coordination.
By Kathleen Doheny. In U.S. News & World Report
http://www.***.com/

UK researchers present findings from Kentucky {*filter*} cancer patients
with disease relapse
The University of Kentucky Markey Cancer Center {*filter*} oncologist Dr.
Suleiman Massarweh and his research team presented findings from their
studies on relapse of {*filter*} cancer at the San Antonio {*filter*} Cancer
Symposium this month.
EurekAlert
http://www.***.com/

Cleveland Clinic researcher discovers genetic cause of thyroid cancer
Genetic analysis revises treatment recommendations related to thyroid
cancer.
EurekAlert
http://www.***.com/

Many cancer cases, now manageable, although roadblocks remain
Since 1991 alone, there's been more than an 18 percent reduction in
deaths from cancer.
By Amanda Gardner. In USA Today
http://www.***.com/

New genetic fault (a KIF5B-RET gene fusion) linked to lung cancer in
non-smokers
Korean scientists have discovered a gene fault that may be behind
thousands of cases of lung cancer worldwide, particularly in non-
smokers.
In Cancer Research UK
http://www.***.com/

Promising treatments for {*filter*} cancers presented by John Theurer
Cancer Center researchers at American Society of Hematology meeting
Research includes phase III bone marrow transplant study presented as
first abstract in the scientific plenary session.
EurekAlert
http://www.***.com/

Previously unconnected molecular networks conspire to promote cancer
An inflammation-promoting protein triggers deactivation of a tumor-
suppressor that usually blocks cancer formation via the NOTCH
signaling pathway, a team of researchers led by scientists at The
University of Texas MD Anderson Cancer Center reports today in
Molecular Cell.
EurekAlert
http://www.***.com/

Enzyme that flips switch on cells' sugar cravings could be anti-cancer
target
Cancer cells tend to take up more glucose than healthy cells, and
researchers are increasingly interested in exploiting this tendency
with {*filter*} that target cancer cells' altered metabolism.
EurekAlert
http://www.***.com/

Research Sheds Light on Gene Mutation's Role in Rare Tumors
Findings could spur new treatments for more common cancers, study
suggests.
In U.S. News & World Report
http://www.***.com/

NCI's Varmus Changes the Metaphor: There Is No War on 'Cancer'
Dr. Harold Varmus, Director of the National Cancer Institute (NCI) of
the National Institutes of Health (NIH).
In Medscape
http://www.***.com/

{*filter*} cancer linked to heart disease: study
Women who carry the genetic mutations that put them at higher risk of
{*filter*} cancer may also be facing an increased risk of heart failure,
Canadian researchers are reporting.
By Sharon Kirkey. Montreal Gazette
http://www.***.com/ {*filter*}+cancer+linked+heart+dise...

Des mutations identiques d'un mme gne lies plusieurs cancers
rares
Des mutations identiques d'un mme gne jouant un r?le cl dans la
prservation de la sant sont lies plusieurs formes rares de
cancers de l'ovaire, de l'utrus et des testicules, rvle une tude
mene au Canada et publie mercredi aux Etats-Unis. Dans Les Echos
http://www.***.com/

Cancer pdiatrique: tourner le dos ses mdecins?
Chaque anne, des parents qubcois contestent les traitements donns
leur enfant gravement malade, en gnral parce qu'ils disent avoir
dcouvert une option sans douleur. Qualifi de ?problme crucial? et
de sujet ?particulirement controvers? par la Socit internationale
d'oncologie pdiatrique, le phnomne rappelle la phobie des vaccins.
Et peut provoquer des conflits dchirants, quand ce n'est pas
carrment la mort.
Par Marie-Claude Malboeuf. Dans {*filter*}presse.
http://www.{*filter*}presse.ca/actualites/quebec-canada/education/201112/2...

Cancer du sein et du col de lutrus : Vaincre les tabous par le
dpistage prcoce
La mortalit lie aux cancers du sein et du col de lutrus devient de
plus en plus proccupante. Au Sngal, le cancer occupe la deuxime
cause de mortalit des femmes. Le dpistage prcoce est le moyen le
plus efficace pour mettre fin la souffrance de ces nombreuses femmes
qui sollicitent des soins tardivement, au moment o les mdecins ne
peuvent quasiment plus rien faire. Pour cette raison, le dpistage
doit tre dmocratis et dcentralis. Cest dans ce cadre que se
situe la campagne de promotion de la planification familiale et du
dpistage des cancers du sein et du col de lutrus dans les rgions
de Matam et Saint-Louis.
Par Ma?mouna Gueye. Dans Le Soleil
http://www.***.com/

Cancer du sein : la piste d'un vaccin test sur la souris
Le volume d'une tumeur mammaire de souris a t rduit de 80 %.
Par Martine Perez. Dans Le Figaro
http://www.***.com/

Etats-Unis: avance majeure en vue d'un traitement personnalis des
cancers
Des chercheurs amricains sont parvenus maintenir en vie, en
laboratoire et jusqu' une dure de deux ans, des cellules tumorales,
une avance mme de changer radicalement la manire de traiter les
personnes atteintes d'un cancer, rvle lundi une tude.
AFP
http://www.***.com/

Cancer Blog Marc Lacroix Le Blogue du Cancer
http://www.***.com/

Marc Lacroix InTextoResearch Baelen  (12/2011)